lapatinib has been researched along with isomethyleugenol in 1 studies
| Studies (lapatinib) | Trials (lapatinib) | Recent Studies (post-2010) (lapatinib) | Studies (isomethyleugenol) | Trials (isomethyleugenol) | Recent Studies (post-2010) (isomethyleugenol) |
|---|---|---|---|---|---|
| 1,919 | 305 | 1,442 | 33,847 | 127 | 11,831 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arai, N; Ebata, T; Fujii, S; Hattori, N; Kondo, H; Liu, YY; Mukai, H; Takeshima, H; Takeuchi, C; Ushijima, T; Yamashita, S | 1 |
1 other study(ies) available for lapatinib and isomethyleugenol
| Article | Year |
|---|---|
HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity.
Topics: Breast Neoplasms; Cell Line, Tumor; Female; Glucose; Humans; Lapatinib; Methylation; Peroxisomal Multifunctional Protein-2; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2 | 2023 |